• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

双氟沙星(A-56619)和A-56620对临床厌氧菌的体外活性。

Activity of difloxacin (A-56619) and A-56620 against clinical anaerobic bacteria in vitro.

作者信息

Bansal M B, Thadepalli H

出版信息

Antimicrob Agents Chemother. 1987 Apr;31(4):619-21. doi: 10.1128/AAC.31.4.619.

DOI:10.1128/AAC.31.4.619
PMID:3606066
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC174790/
Abstract

We determined the MICs of difloxacin (A-56619) and A-56620 against anaerobic bacteria and assessed the effects of alterations in pH, size of inoculum, addition of human serum, and repeated exposure to subinhibitory levels of antibiotics. We tested for synergism of these drugs with cefoxitin against Bacteroides spp. We found that difloxacin and A-56620 were as active as ciprofloxacin, inhibiting about 90% of B. fragilis (4 micrograms/ml) and other Bacteroides spp. (8 micrograms/ml), A-56620 being more active than difloxacin against several isolates. Increased inoculum size and changes in pH did not alter their MICs much, but human serum and exposure to sub-MICs of antibiotic effected increases in their MICs against Bacteroides spp. Cefoxitin was not synergistic with either difloxacin or A-56620 against B. fragilis.

摘要

我们测定了双氟沙星(A-56619)和A-56620对厌氧菌的最低抑菌浓度(MIC),并评估了pH值变化、接种量大小、添加人血清以及反复接触亚抑菌浓度抗生素的影响。我们测试了这些药物与头孢西丁对拟杆菌属的协同作用。我们发现双氟沙星和A-56620与环丙沙星活性相当,抑制约90%的脆弱拟杆菌(4微克/毫升)和其他拟杆菌属(8微克/毫升),A-56620对几种分离株的活性比双氟沙星更强。接种量增加和pH值变化对其MIC影响不大,但人血清和接触抗生素亚抑菌浓度会导致其对拟杆菌属的MIC增加。头孢西丁与双氟沙星或A-56620对脆弱拟杆菌均无协同作用。

相似文献

1
Activity of difloxacin (A-56619) and A-56620 against clinical anaerobic bacteria in vitro.双氟沙星(A-56619)和A-56620对临床厌氧菌的体外活性。
Antimicrob Agents Chemother. 1987 Apr;31(4):619-21. doi: 10.1128/AAC.31.4.619.
2
Susceptibilities of 428 gram-positive and -negative anaerobic bacteria to Bay y3118 compared with their susceptibilities to ciprofloxacin, clindamycin, metronidazole, piperacillin, piperacillin-tazobactam, and cefoxitin.428株革兰氏阳性和阴性厌氧菌对Bay y3118的敏感性及其对环丙沙星、克林霉素、甲硝唑、哌拉西林、哌拉西林-他唑巴坦和头孢西丁的敏感性比较。
Antimicrob Agents Chemother. 1993 Aug;37(8):1649-54. doi: 10.1128/AAC.37.8.1649.
3
In vitro activities of A-56619 (difloxacin) and A-56620, two aryl fluoroquinolones.两种芳基氟喹诺酮类药物A-56619(二氟沙星)和A-56620的体外活性
Chemotherapy. 1988;34(4):298-307. doi: 10.1159/000238583.
4
Influence of environmental factors on the in vitro efficacy of ciprofloxacin against anaerobic bacteria.环境因素对环丙沙星体外抗厌氧菌疗效的影响。
Chemotherapy. 1989;35(3):153-9. doi: 10.1159/000238663.
5
In vitro activity of difloxacin against canine bacterial isolates.双氟沙星对犬源细菌分离株的体外活性
J Vet Diagn Invest. 2000 May;12(3):218-23. doi: 10.1177/104063870001200304.
6
Increased activity of a new chlorofluoroquinolone, BAY y 3118, compared with activities of ciprofloxacin, sparfloxacin, and other antimicrobial agents against anaerobic bacteria.新型氯氟喹诺酮BAY y 3118与环丙沙星、司帕沙星及其他抗菌药物相比,对厌氧菌的活性增强。
Antimicrob Agents Chemother. 1994 Jul;38(7):1671-4. doi: 10.1128/AAC.38.7.1671.
7
In-vitro and in-vivo potency of five new fluoroquinolones against anaerobic bacteria.五种新型氟喹诺酮类药物对厌氧菌的体外和体内抗菌效能
J Antimicrob Chemother. 1986 Dec;18(6):693-701. doi: 10.1093/jac/18.6.693.
8
In vitro activity of cefbuperazone, a new cephamycin, against anaerobic bacteria.新型头孢霉素头孢哌酮对厌氧菌的体外活性
Antimicrob Agents Chemother. 1985 Apr;27(4):640-2. doi: 10.1128/AAC.27.4.640.
9
The in-vitro activity of tosufloxacin, a new fluorinated quinolone, compared with that of ciprofloxacin and temafloxacin.新型氟喹诺酮类药物托氟沙星与环丙沙星和替马沙星的体外活性比较。
J Antimicrob Chemother. 1991 Nov;28(5):719-25. doi: 10.1093/jac/28.5.719.
10
Comparative antibacterial activities of temafloxacin hydrochloride (A-62254) and two reference fluoroquinolones.盐酸替马沙星(A-62254)与两种氟喹诺酮类对照品的抗菌活性比较
Antimicrob Agents Chemother. 1987 Nov;31(11):1768-74. doi: 10.1128/AAC.31.11.1768.

本文引用的文献

1
In vitro activity of ciprofloxacin, a new carboxyquinoline antimicrobial agent.新型羧基喹啉抗菌剂环丙沙星的体外活性
Antimicrob Agents Chemother. 1984 Mar;25(3):331-5. doi: 10.1128/AAC.25.3.331.
2
In vitro susceptibility of anaerobic bacteria to ciprofloxacin (Bay o 9867).厌氧菌对环丙沙星(拜奥9867)的体外敏感性
Antimicrob Agents Chemother. 1984 Nov;26(5):785-6. doi: 10.1128/AAC.26.5.785.
3
Ciprofloxacin, a quinolone carboxylic acid compound active against aerobic and anaerobic bacteria.环丙沙星,一种对需氧菌和厌氧菌均有活性的喹诺酮羧酸化合物。
Antimicrob Agents Chemother. 1984 Mar;25(3):319-26. doi: 10.1128/AAC.25.3.319.
4
Rapid selection of organisms with increasing resistance on subinhibitory concentrations of norfloxacin in agar.在琼脂中对亚抑菌浓度的诺氟沙星产生耐药性增加的微生物的快速筛选。
Antimicrob Agents Chemother. 1983 Jan;23(1):188-9. doi: 10.1128/AAC.23.1.188.
5
Therapeutic evaluation of difloxacin (A-56619) and A-56620 for experimentally induced Bacteroides fragilis-associated intra-abdominal abscess.地氟沙星(A-56619)和A-56620对实验性诱导的脆弱拟杆菌相关性腹腔内脓肿的治疗评估。
Antimicrob Agents Chemother. 1986 Oct;30(4):574-6. doi: 10.1128/AAC.30.4.574.
6
In vitro activity of ticarcillin against anaerobic bacteria compared with that of carbenicillin and penicillin.替卡西林对厌氧菌的体外活性与羧苄西林和青霉素的比较。
Antimicrob Agents Chemother. 1977 Feb;11(2):258-61. doi: 10.1128/AAC.11.2.258.